Artal Group S.A. 13F holdings
Artal Group S.A. reported 2 positions with a total reported value of $931.1M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-13. Top holdings by reported value: CAVA Cava Group Inc (54.9%), LXRX Lexicon Pharmaceuticals Inc (45.1%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Artal Group S.A. files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
2 largest of 2 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| CAVA Cava Group Inc | 6,507,990 | $510.7M | 54.9% |
| LXRX Lexicon Pharmaceuticals Inc | 175,156,062 | $420.4M | 45.1% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| LXRX Lexicon Pharmaceuticals Inc | 154,734,327 | 175,156,062 | +13.2% | $420.4M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| CAVA Cava Group Inc | 9,507,990 | 6,507,990 | -31.6% | $510.7M |
CIK 1053906 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
